PROM1 and malignant colon neoplasm: Previous research reported that human colon cancer SW620 cells have both CD133+ and CD133− phenotypes: in vitro, CD133+ SW620 cells had a higher proliferative capacity and were more irradiation- and chemotherapy-resistant compared with CD133− cells (2).